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Independent from age, lifestyle, and other cardiovascular risk factors, being overweight or obese is associated with a progressively increased risk of ischemic stroke. 1 The prevalence of obesity, specifically in the elderly population, who are already at the highest risk of stroke, is increasing worldwide and is associated with both escalating healthcare costs and disability. 2 Although obesity is a primary risk factor for stroke and a major public health concern in the elderly patient population, there are limited data available on the impact of obesity on post-stroke rehabilitation outcomes. For the estimated 800,000 Americans who sustain a stroke annually, a primary goal of stroke rehabilitation programs is to maximize long-term functional mobility and ambulation. Obesity would be anticipated to negatively affect the achievement of poststroke functional mobility and ambulation goals. The primary objective of this study was to evaluate the association between pretreatment body mass index (BMI) and change in motor impairment and functional mobility performance in chronic hemiparetic stroke subjects who participated in an interventional study aimed at improving ambulation.
Our first hypothesis was that stroke participants with a higher BMI would have a lower level of pretreatment motor impairment, measured by the Fugl-Meyer (FM) score, on the basis of an apparent obesity paradox 3 that proposes that overweight and obese patients may have a prestroke elevation in cholesterol levels, which preferentially predisposes them to small vessel disease and thus to less severe strokes. However, on the basis of an established association between obesity and functional disability in the nonstroke population, 4Y11 our second hypothesis was that BMI would be positively correlated with pretreatment functional mobility deficits, as measured by the modified Emory Functional Ambulation Profile (mEFAP) component scores. Our third hypothesis was that BMI would be significantly negatively associated with change in motor impairment level and functional ambulation performance in response to a 12-wk period of ambulation training. This study is the first to examine the association between pretreatment BMI and change in motor impairment and functional mobility performance in response to an ambulation training rehabilitation intervention in the chronic post-stroke patient population. If pretreatment BMI is strongly negatively associated with post-stroke rehabilitation gains, then a high BMI should be recognized as a potential barrier to achieving optimal therapy gains and should thus be independently factored in the formulation of longer-term stroke rehabilitation goals.
METHODS

Study Design
This study is a secondary analysis of data collected in a randomized controlled clinical stroke trial (Bparent study[), which enrolled 110 hemiparetic subjects. The objective of the parent study was to compare the lower limb motor relearning effect of a peroneal nerve stimulator vs. usual-care (ankle foot orthosis or no device) treatment. The enrolled subjects were randomized to either a peroneal nerve stimulator or a usual-care group and participated in a 12-wk ambulation training treatment period using the assigned device. This present study analyzed a subset of pretreatment and endof-treatment lower limb motor impairment and functional mobility data collected in the parent study. For the purposes of this secondary analysis, the BMI was calculated on the basis of pretreatment weight and height measurements, which were available for 108 subjects.
Participants
The protocols of both the parent study and this secondary analysis were approved by the institutional review board of the involved academic medical centers; each subject gave written consent before participation. All subjects enrolled in the parent study were a minimum of 18 yrs of age and were medically stable. The subjects demonstrated unilateral hemiparesis, with ankle dorsiflexion strength of no greater than 4/5 on the Medical Research Council Scale while standing. Each subject demonstrated dorsiflexion weakness during ambulation, such that inefficient gait patterns with the need for compensatory strategies were exhibited when ambulating a minimum of 9 m. Subjects with concomitant neurologic diagnoses, uncompensated hemineglect, severely impaired cognition and communication, fixed ankle contracture, peroneal nerve injury, genu recurvatum, or a history of botulinum toxin injection to the affected lower limb in the preceding 3 mos were excluded. No inclusion or exclusion selection criterion of the parent study was contingent on subject BMI.
Variables
Body Mass Index (Independent Variable)
The BMI 12 is defined as the body weight divided by the square of the height (kg/m 2 ) and is a widely used diagnostic tool to identify weight problems within a population. A BMI less than 18.5 is defined as an underweight condition, a BMI of 18.5Y25 is defined as optimal weight, a BMI greater than 25 is defined as an overweight condition, a BMI greater than 30 is defined as obese (Class I, BMI 30Y35; Class II, BMI 35Y40), and a BMI greater than 40 is defined as morbid obesity (Class III).
Lower Limb Motor Impairment and Functional Ambulation Measures (Dependent Variables)
FM Assessment. The FM assessment 13 has been widely used as a clinical and research instrument to measure post-stroke motor impairment. Subjects are assessed for the presence or absence of lower limb reflexes, flexor and extensor synergy patterns, and volitional movement; coordination (tremor, dysmetria); and speed of movement. The validity 13 and the interrater and test-retest reliability of the FM assessment has been demonstrated. 14, 15 The lower limb portion of the FM assessment was performed in the parent study for a maximum FM assessment score of 34. The change of the lower limb FM score was used as a dependent variable, which was defined as the measure at 12 wks subtracted by the measure at baseline.
Modified Emory Functional Ambulation Profile. The mEFAP is a clinical test that measures the time to ambulate through five common environmental terrains. Specific tasks include (1) a 5-m walk on a hard floor; (2) a 5-m walk on a carpeted surface; (3) rising from a chair, a 3-m walk, and returning to a seated position (the Btimed up and go[ test); (4) a standardized obstacle course; and (5) stair ascent and descent. The test was administered using a hand-held stopwatch in the sequence listed, and timed subscores of the five components were recorded. The validity 16 and the interrater reliability 16, 17 of the mEFAP have been determined. The change of the mEFAP timed score, for each of the five component tasks, was used as a dependent variable, which was defined as the measure at 12 wks subtracted by the measure at baseline.
Statistical Analysis
To understand the demographics of the study population, exploratory analysis was performed. Normalcy of distribution of data was determined by looking at histograms and normal probability plots and by the Kolmogorov-Smirnov and Shapiro-Wilk tests. Pearson product-moment correlation coefficients (r) were generated to quantify the strength and the direction of the association between the pretreatment BMI and the pretreatment FM score and the five component scores of the mEFAP. A series of linear regression models that controlled for age, sex, stroke type (hemorrhagic vs. ischemic), interval post stroke, and treatment device intervention (peroneal nerve stimulator vs. usual care) were then used to determine the strength of association between the pretreatment BMI and the change in motor impairment and functional ambulation measures in response to the 12-wk treatment intervention. We handled missing data in the models by performing listwise deletion. Residual plots were used to verify normality of the model error terms.
RESULTS
The BMI was calculated on the basis of weight and height, which were recorded for 108 subjects. Participant characteristics and pretreatment data are presented in Table 1 . Pretreatment BMI did not correlate with pretreatment FM score or mEFAP component scores. Change in FM and mEFAP component scores after the 12-wk intervention is presented in Table 2 . For all subjects, there was a statistically significant correlation between pretreatment BMI and change in the FM score (r = j0.218, P = 0.034) and change in up and go mobility score (r = 0.224, P = 0.030) at the end of the 12-wk intervention period. In a series of linear regression models, we adjusted for age, sex, stroke type (hemorrhagic vs. ischemic), interval post stroke, and treatment device intervention. We found that change in the FM score continued to be significantly negatively associated with pretreatment BMI (A = j0.207, P = 0.036). Similarly, change in up and go mobility score continued to be positively associated with pretreatment BMI (A = 0.216, P = 0.03) at the end of the intervention period. Pretreatment BMI (P 9 0.05) was not associated with change in mEFAP component scores in floor, carpet, obstacles, or stair climbing.
DISCUSSION
A primary finding in this study was that BMI was not significantly negatively associated with pretreatment motor impairment (FM score). This finding does not support the obesity paradox 3 that proposes that an overweight or an obese patient is predisposed to specific stroke types that result in less severe motor deficits and thus a lower degree of motor impairment. A possible explanation for this finding is that the parent study enrollment criteria, which required a minimum ability to ambulate 30 ft at study entry, may have biased our subject pool by excluding subjects with greater levels of motor impairment, who, theoretically, may have had lower BMIs. Alternatively, the study sample size may simply have been inadequate to reflect a disparate incidence of specific stroke type and severity related to BMI and associated comorbidities. 18 A secondary finding in this present study was that BMI was not significantly positively associated with pretreatment functional mobility deficits (mEFAP component scores). This finding is at odds with published literature for both healthy adult and disabled patient populations. Obesity in otherwise healthy adult patient populations has been shown to have a negative impact on functional ambulation, 6,7,11 balance, 7,8 fall frequency, 7 and physical disability. 4, 5, 9, 10 The coexistence of a high BMI and two or more physical impairments has been demonstrated to significantly increase the adjusted risk of longer-term walking limitation as compared with normal-weight persons with no physical impairments. 19 The absence of an association between BMI and pretreatment mEFAP scores in this study may similarly be explained by either the inadequate sample size in the parent study or the enrollment criteria, which excluded subjects with the greatest level of mobility limitation. Alternatively, a high BMI may be associated with limitation in endurancedependent functional performance tasks not measured by the mEFAP, and thus, the mEFAP may be suboptimal as a measurement tool.
An important third study finding was that pretreatment BMI was significantly negatively associated with change in motor impairment (FM scores) and positively associated with change in up and go mEFAP performance at the end of the 12-wk intervention period. Chronic hemiparetic patients with a higher BMI were less likely to demonstrate gains in motor impairment or improvement on their up and go performance, irrespective of the treatment intervention (peroneal nerve stimulator or usual care). These findings are in accord with Kalichman et al., 20 who found a negative correlation between BMI and relative improvement of Functional Independence Measure score at the end of a 12-wk period of inpatient acute stroke rehabilitation. This present study, however, is the first to suggest that BMI may be predictive of response to a rehabilitation intervention in the chronic (93 mos) post-stroke period. Of note, a significant association with BMI was found only for the up and go mEFAP component, the only mEFAP task that commences from a seated position. Previous studies have demonstrated a correlation between paretic and bilateral plantarflexion strength and up and go testing, 21, 22 and thus, performance gains on this task, relative to the other mEFAP tasks, may be disproportionately dependent on plantarflexion strength gains. Theoretically, if duration, intensity, or frequency of walking was less during the 12-wk intervention period for the subjects with higher BMIs, the result may be less plantarflexion strengthening and thus less improvement on the up and go mEFAP task relative to the other component tasks. Similarly speculative, the significant negative association between change in FM score and BMI may be related to compliance with the rehabilitation intervention (i.e., duration, intensity, and distance of walking), irrespective of treatment device, which may have been disproportionately less because of BMI-associated medical comorbidities.
Interpretation of this secondary analysis is primarily limited by the study design. The parent study was limited to chronic stroke survivors who were able to ambulate up to 9 m, and inclusion/ exclusion criteria resulted in the exclusion of subjects with more severe motor impairment and functional limitations. Secondly, the BMI is recognized as an imperfect measure that has been criticized for making overly simplistic assumptions about distribution of muscle and bone mass, particularly in the elderly patient population. Thirdly, the linear regression models predict a magnitude of change in the FM or mEFAP component scores associated with BMI level that, although statistically significant, may not translate into a clinical significant difference for any individual stroke survivor.
In summary, obesity is a growing public health concern in the elderly patient population and is associated with an increased risk of stroke. Although being overweight or obese might reasonably be anticipated to negatively affect post-stroke motor impairment and functional mobility, there was no significant association between pretreatment FM or mEFAP component scores and BMI in chronic stroke survivors. Subjects with a higher pretreatment BMI, however, were less likely to demonstrate improvement in their level of motor impairment and performance on an up and go mobility task in response to 12 wks of ambulation training, irrespective of the treatment intervention group. These preliminary findings should be verified using a larger, more generalizable sample size to determine whether BMI is actually predictive of response to post-stroke rehabilitation interventions. Regardless, this study suggests that the BMI should be considered when formulating stroke rehabilitation goals and also reiterates the importance of addressing obesity not simply as a risk factor for stroke but also as a potential barrier to maximizing longer-term post-stroke motor and functional recovery.
